Cargando…

The Molecular Basis of Retinoids’ Use in Breast Cancer Chemoprevention

Detalles Bibliográficos
Autores principales:	Karamouzis, Michalis V., Konstantinopoulos, Panagiotis A., Papavassiliou, Athanasios G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2007
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618216/ https://www.ncbi.nlm.nih.gov/pubmed/17452770 http://dx.doi.org/10.1155/2007/128535

Ejemplares similares

EGF-R is Expressed and AP-1 and NF-κ:B Are Activated in Stromal Myofibroblasts Surrounding Colon Adenocarcinomas Paralleling Expression of COX-2 and VEGF
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2007)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
por: Simatou, Aristofania, et al.
Publicado: (2020)

Upgraded role of autophagy in colorectal carcinomas
por: Koustas, Evangelos, et al.
Publicado: (2018)

Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
por: Anestis, Aristomenis, et al.
Publicado: (2020)

Compartmentalisation of EGFR signalling might potentiate the optimal use of EGFR tyrosine kinase inhibitors in cancer therapeutics
por: Karamouzis, M V, et al.
Publicado: (2007)

Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
por: Bokas, Alexandros, et al.
Publicado: (2020)

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors
por: Koustas, Evangelos, et al.
Publicado: (2020)

Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID‐19?
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

The Interplay of Autophagy and Tumor Microenvironment in Colorectal Cancer—Ways of Enhancing Immunotherapy Action
por: Koustas, Evangelos, et al.
Publicado: (2019)

Inhibition of c‐MET increases the antitumour activity of PARP inhibitors in gastric cancer models
por: Koustas, Evangelos, et al.
Publicado: (2020)

The role of autophagy in the treatment of BRAF mutant colorectal carcinomas differs based on microsatellite instability status
por: Koustas, Evangelos, et al.
Publicado: (2018)

HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas
por: Karamouzis, Michalis V., et al.
Publicado: (2015)

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models
por: Mihailidou, Chrysovalantou, et al.
Publicado: (2017)

Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
por: Sarantis, Panagiotis, et al.
Publicado: (2022)

Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy
por: Koustas, Evangelos, et al.
Publicado: (2021)

Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas
por: Zoi, Ilianna, et al.
Publicado: (2019)

Pancreatic Cancer and Cachexia—Metabolic Mechanisms and Novel Insights
por: Poulia, Kalliopi Anna, et al.
Publicado: (2020)

Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules
por: Vallilas, Christos, et al.
Publicado: (2021)

Retinoids in cancer chemoprevention and therapy: Meta-analysis of randomized controlled trials
por: Chen, Shuting, et al.
Publicado: (2022)

Decision aids for breast cancer chemoprevention
por: Juraskova, Ilona, et al.
Publicado: (2013)

Leiomyosarcoma of the Prostate: Case Report and Review of 54 Previously Published Cases
por: Vandoros, Gerasimos P., et al.
Publicado: (2008)

Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis
por: Shimizu, Masahito, et al.
Publicado: (2012)

Retinoids and breast cancer: new clues to increase their activity and selectivity
por: Garattini, Enrico, et al.
Publicado: (2012)

Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives
por: Koustas, Evangelos, et al.
Publicado: (2022)

Cancer Chemoprevention
por: Amin, Amr, et al.
Publicado: (2012)

The Implication of Autophagy in Gastric Cancer Progression
por: Koustas, Evangelos, et al.
Publicado: (2021)

Pancreatic Cancer: Molecular, Biochemical, Chemopreventive, and Therapeutic Aspects
por: Iovanna, Juan, et al.
Publicado: (2010)

The Biology and Therapeutic Potential of the Src-YAP Axis in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2022)

Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer
por: Koustas, Evangelos, et al.
Publicado: (2019)

Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
por: Sarantis, Panagiotis, et al.
Publicado: (2021)

Implication of gut microbiome in immunotherapy for colorectal cancer
por: Koustas, Evangelos, et al.
Publicado: (2022)

Lung Cancer through Transcription Factors
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Retinoids in Embryonic Development
por: Schubert, Michael, et al.
Publicado: (2020)

Polycystins, mechanotransduction and cancer development
por: Papavassiliou, Kostas A., et al.
Publicado: (2022)

Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks
por: Stravopodis, Dimitrios J., et al.
Publicado: (2023)

Dietary Agents in Cancer Chemoprevention and Treatment
por: Raffoul, Julian J., et al.
Publicado: (2012)

Molecular Basis of Prostate Cancer and Natural Products as Potential Chemotherapeutic and Chemopreventive Agents
por: Bai, Bingke, et al.
Publicado: (2021)

Retinoids, breast cancer and NK cells.
por: Villa, M. L., et al.
Publicado: (1993)

Chemoprevention of metastasis
por: Emenaker, Nancy J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u43c1768bdlhu78raov46hotln